These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 8911142)

  • 1. Cytotoxic activity against tumour cells mediated by intermediate TCR cells in the liver and spleen.
    Kawamura T; Kawachi Y; Moroda T; Weerasinghe A; Iiai T; Seki S; Tazawa Y; Takada G; Abo T
    Immunology; 1996 Sep; 89(1):68-75. PubMed ID: 8911142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of NKT cells in resistance against infection with Toxoplasma gondii and in expression of heat shock protein 65 in the host macrophages.
    Nakano Y; Hisaeda H; Sakai T; Ishikawa H; Zhang M; Maekawa Y; Zhang T; Takashima M; Nishitani M; Good RA; Himeno K
    Microbes Infect; 2002 Jan; 4(1):1-11. PubMed ID: 11825769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural cell-mediated cytotoxicity (NCMC) against NK-sensitive tumours in vitro by murine spleen Ly-6C+ natural T cells.
    Martiniello R; Burton RC; Smart YC
    Int J Cancer; 1997 Feb; 70(4):450-60. PubMed ID: 9033654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell clones expressing the natural killer cell-related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function.
    Ferrini S; Cambiaggi A; Meazza R; Sforzini S; Marciano S; Mingari MC; Moretta L
    Eur J Immunol; 1994 Oct; 24(10):2294-8. PubMed ID: 7925558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD3+CD16+NK1.1+B220+ large granular lymphocytes arise from both alpha-beta TCR+CD4-CD8- and gamma-delta TCR+CD4-CD8- cells.
    Koyasu S
    J Exp Med; 1994 Jun; 179(6):1957-72. PubMed ID: 8195719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of skin xenograft rejection by depleting T-cell receptor alpha beta-bearing cells without T-cell receptor gamma delta-bearing cells or natural killer cells by monoclonal antibody.
    Nishimura Y; Eto M; Maeda T; Hiromatsu K; Kobayashi N; Nomoto K; Kong YY; Nomoto K
    Immunology; 1994 Oct; 83(2):196-204. PubMed ID: 7835935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationships between intermediate TCR cells and NK1.1+ T cells in various immune organs. NK1.1+ T cells are present within a population of intermediate TCR cells.
    Watanabe H; Miyaji C; Kawachi Y; Iiai T; Ohtsuka K; Iwanage T; Takahashi-Iwanaga H; Abo T
    J Immunol; 1995 Sep; 155(6):2972-83. PubMed ID: 7673715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The regulation of phenotype and function of human liver CD3+/CD56+ lymphocytes, and cells that also co-express CD8 by IL-2, IL-12 and anti-CD3 monoclonal antibody.
    Jin Y; Fuller L; Carreno M; Esquenazi V; Tzakis AG; Miller J
    Hum Immunol; 1998 Jun; 59(6):352-62. PubMed ID: 9634197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic and functional analysis of murine CD3+,CD4-,CD8- TCR-gamma delta-expressing peripheral T cells.
    Cron RQ; Gajewski TF; Sharrow SO; Fitch FW; Matis LA; Bluestone JA
    J Immunol; 1989 Jun; 142(11):3754-62. PubMed ID: 2523934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel surface molecule expressed by long-term cultured T and natural killer cells is involved in cell activation.
    Ferrini S; Cantoni C; Ciccone E; Biassoni R; Prigione I; Bottino C; Venzano P; Moretta L
    Eur J Immunol; 1991 Sep; 21(9):1981-7. PubMed ID: 1832383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mouse liver T cells: their change with aging and in comparison with peripheral T cells.
    Tsukahara A; Seki S; Iiai T; Moroda T; Watanabe H; Suzuki S; Tada T; Hiraide H; Hatakeyama K; Abo T
    Hepatology; 1997 Aug; 26(2):301-9. PubMed ID: 9252138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expansion of intermediate T cell receptor cells expressing interleukin-2 receptor alpha- beta+, CD8alpha+ beta+, and lymphocyte function-associated antigen-1+ in the liver in association with intrahepatic islet xenograft rejection from rat to mouse: prevention of rejection with anti-interleukin-2 receptor beta monoclonal antibody treatment.
    Ohtsuka K; Yasunami Y; Ikehara Y; Nagai T; Kodama S; Maki T; Tomita A; Abo T; Ikeda S
    Transplantation; 1997 Aug; 64(4):633-9. PubMed ID: 9293878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autologous killing by a population of intermediate T-cell receptor cells and its NK1.1+ and NK1.1- subsets, using Fas ligand/Fas molecules.
    Moroda T; Iiai T; Suzuki S; Tsukahara A; Tada T; Nose M; Hatakeyama K; Seki S; Takeda K; Watanabe H; Abo T
    Immunology; 1997 Jun; 91(2):219-26. PubMed ID: 9227320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of intermediate TCR cells in the liver of mice with respect to their unique IL-2R expression.
    Watanabe H; Iiai T; Kimura M; Ohtsuka K; Tanaka T; Miyasaka M; Tsuchida M; Hanawa H; Abo T
    Cell Immunol; 1993 Jul; 149(2):331-42. PubMed ID: 8330313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural killer (NK)-like cytotoxic activity of allospecific T cell receptor-gamma,delta+ T cell clones. Distinct receptor-ligand interactions mediate NK-like and allospecific cytotoxicity.
    Koide J; Rivas A; Engleman EG
    J Immunol; 1989 Jun; 142(12):4161-8. PubMed ID: 2470816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative resistance of intermediate TCR cells to anti-CD3 mAb in mice in vivo and their partial functional characterization.
    Tsuchida M; Iiai T; Watanabe H; Abo T
    Cell Immunol; 1992 Nov; 145(1):78-90. PubMed ID: 1423648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-4 producing CD4+ TCR alpha beta int liver lymphocytes: influence of thymus, beta 2-microglobulin and NK1.1 expression.
    Emoto M; Emoto Y; Kaufmann SH
    Int Immunol; 1995 Nov; 7(11):1729-39. PubMed ID: 8580071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gamma delta T cells in the pathobiology of murine acute graft-versus-host disease. Evidence that gamma delta T cells mediate natural killer-like cytotoxicity in the host and that elimination of these cells from donors significantly reduces mortality.
    Ellison CA; MacDonald GC; Rector ES; Gartner JG
    J Immunol; 1995 Nov; 155(9):4189-98. PubMed ID: 7594574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel functional cell surface dimer (Kp43) expressed by natural killer cells and T cell receptor-gamma/delta+ T lymphocytes. I. Inhibition of the IL-2-dependent proliferation by anti-Kp43 monoclonal antibody.
    Aramburu J; Balboa MA; Ramírez A; Silva A; Acevedo A; Sánchez-Madrid F; De Landázuri MO; López-Botet M
    J Immunol; 1990 Apr; 144(8):3238-47. PubMed ID: 1691231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting of T or NK lymphocytes against tumor cells by bispecific monoclonal antibodies: role of different triggering molecules.
    Ferrini S; Cambiaggi A; Cantoni C; Canevari S; Mezzanzanica D; Colnaghi MI; Moretta L
    Int J Cancer Suppl; 1992; 7():15-8. PubMed ID: 1428398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.